GemPharmatech Future Growth
Future criteria checks 5/6
GemPharmatech is forecast to grow earnings and revenue by 31.2% and 27.1% per annum respectively. EPS is expected to grow by 31% per annum. Return on equity is forecast to be 11.1% in 3 years.
Key information
31.2%
Earnings growth rate
31.0%
EPS growth rate
| Life Sciences earnings growth | 29.3% |
| Revenue growth rate | 27.1% |
| Future return on equity | 11.1% |
| Analyst coverage | Good |
| Last updated | 27 Feb 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 1,074 | 296 | N/A | N/A | 8 |
| 12/31/2024 | 801 | 202 | N/A | N/A | 3 |
| 12/31/2023 | 622 | 159 | N/A | N/A | N/A |
| 9/30/2023 | 585 | 154 | -116 | 96 | N/A |
| 6/30/2023 | 562 | 161 | -107 | 110 | N/A |
| 3/31/2023 | 541 | 165 | -71 | 118 | N/A |
| 12/31/2022 | 517 | 165 | -84 | 106 | N/A |
| 9/30/2022 | 500 | 168 | -25 | 122 | N/A |
| 6/30/2022 | 466 | 160 | -16 | 125 | N/A |
| 3/31/2022 | 433 | 137 | -14 | 96 | N/A |
| 12/31/2021 | 394 | 125 | 24 | 113 | N/A |
| 12/31/2020 | 262 | 76 | -37 | 130 | N/A |
| 12/31/2019 | 193 | 30 | 19 | 65 | N/A |
| 12/31/2018 | 53 | -6 | 41 | 43 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688046's forecast earnings growth (31.2% per year) is above the savings rate (2.9%).
Earnings vs Market: 688046's earnings (31.2% per year) are forecast to grow faster than the CN market (24.3% per year).
High Growth Earnings: 688046's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688046's revenue (27.1% per year) is forecast to grow faster than the CN market (14.6% per year).
High Growth Revenue: 688046's revenue (27.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688046's Return on Equity is forecast to be low in 3 years time (11.1%).